Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1362768Generated: October 25, 2026

benzyl (2S)-2-amino-3-methylbutanoate → HCID 11285398, compound

https://huagongshe.com/reaction/1362768

Reaction equation

Participants

RoleNameHCIDCharge
Reactantbenzyl (2S)-2-amino-3-methylbutanoateHCID 6950584—
Reactant5-(4'-(Bromomethyl)(1,1'-biphenyl)-2-yl)-1-trityl-1H-tetraazoleHCID 10053461—
ReactantHCID 178447302HCID 178447302—
ProductHCID 11285398HCID 11285398—

Reaction Steps

According to U.S. Pat. No. 5,399,578, Valsartan can also be prepared by reaction of 4-bromomethyl-2′-(1-triphenylmethyltetrazol-5-yl)biphenyl (VI) with L-valine benzyl ester to produce N-[[2′-(1-triphenylmethyltetrazol-5-yl)biphenyl-4-yl]-methyl]-L-valine benzyl ester (VII), followed by treatment with valeryl chloride to produce N-(1-oxopentyl)-N-[[2′-(1-triphenylmethyltetrazol-5-yl)[1,1′-biphenyl]-4-yl]-methyl]-L-valine benzyl ester (VIII). Compound (VIII) is deprotected under acidic conditions to produce N-(1-oxopentyl)-N-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]-methyl]-L-valine benzyl ester (IX), which is then hydrogenated in presence of Pd/C catalyst to give finally Valsartan. The process is shown in scheme II, below:

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07880015B2
Source datasetuspto-grants-2011_02
ORD IDord-904d09ad5c084e2b95404db93c776664
Source noteuspto-grants-2011_02